Outcome of Board Meeting
Un-audited Financial Results for the quarter ended on June 30, 2018 along with limited review report of the Statutory Auditors and the press release in this regard.13-08-2018
13-08-2018
Tata, Dabur among suitors selected for Kraft Heinz's $1 billion India sale: report
The Kraft Heinz India sale has also drawn interest from an arm of Cadila Healthcare and other potential buyers03-08-2018
Zydus Cadila gets USFDA nod for anti-bacterial drug
Zydus Cadila has received final approval from the US health regulator to market Azithromycin for Oral Suspension USP, used to treat bacterial infecti01-08-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company has planned investor interaction through a conference call on August 13, 2018 at 5:00 p.m., post announcement of unaudited financial results for the quarter ended on June 30, 2018.01-08-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Azithromycin for Oral Suspension USP01-08-2018
Zydus Cadila gets USFDA nod to market Vardenafil tablets
Zydus Cadila has received tentative approval from the US health regulator to market Vardenafil Hydrochloride tablets used for the treatment of erect30-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Vardenafil Hydrochloride Tablets USP30-07-2018
Advertisement Of Notice Of Twenty Third Annual General Meeting, E-Voting And Book Closure Information
Advertisement of Notice of twenty Third Annual General Meeting, e-voting and Book Closure information24-07-2018
Board Meeting Scheduled To Be Held On August 13, 2018.
We hereby inform that the meeting of the Board of Directors of the Company will be held on Monday, August 13, 2018 to consider apart from other agenda items to approve the unaudited financial results for the quarter ended on June 30, 2018. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from August...23-07-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Acetylcysteine Injection21-07-2018